170 related articles for article (PubMed ID: 16581361)
1. Maternal serum screening and psychosocial attachment to pregnancy.
Lawson KL; Turriff-Jonasson SI
J Psychosom Res; 2006 Apr; 60(4):371-8. PubMed ID: 16581361
[TBL] [Abstract][Full Text] [Related]
2. A comparison of chorionic villi sampling and amniocentesis: acceptability of procedure and maternal attachment to pregnancy.
Spencer JW; Cox DN
Obstet Gynecol; 1988 Nov; 72(5):714-8. PubMed ID: 3173922
[TBL] [Abstract][Full Text] [Related]
3. Women who are well informed about prenatal genetic screening delay emotional attachment to their fetus.
Rowe H; Fisher J; Quinlivan J
J Psychosom Obstet Gynaecol; 2009 Mar; 30(1):34-41. PubMed ID: 19308781
[TBL] [Abstract][Full Text] [Related]
4. Decisions about amniocentesis by advanced maternal age patients following maternal serum screening may not always correlate clinically with screening results: need for improvement in informed consent process.
Marini T; Sullivan J; Naeem R
Am J Med Genet; 2002 May; 109(3):171-5. PubMed ID: 11977174
[TBL] [Abstract][Full Text] [Related]
5. Fear of pregnancy loss and fetal karyotyping: a place for third-trimester amniocentesis?
Picone O; Senat MV; Rosenblatt J; Audibert F; Tachdjian G; Frydman R
Fetal Diagn Ther; 2008; 23(1):30-5. PubMed ID: 17934295
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the third trimester amniocentesis for fetal karyotyping in women with fear of pregnancy loss].
Picone O; Fuchs F; Sénat MV; Brisset S; Tachdjian G; Audibert F; Fernandez H; Frydman R
J Gynecol Obstet Biol Reprod (Paris); 2008 Jun; 37(4):385-91. PubMed ID: 18191913
[TBL] [Abstract][Full Text] [Related]
7. Miscarriage risk from amniocentesis performed for abnormal maternal serum screening.
Towner D; Currier RJ; Lorey FW; Cunningham GC; Greve LC
Am J Obstet Gynecol; 2007 Jun; 196(6):608.e1-5; discussion 608.e5. PubMed ID: 17547917
[TBL] [Abstract][Full Text] [Related]
8. Effect of fetal movement, ultrasound scans, and amniocentesis on maternal-fetal attachment.
Heidrich SM; Cranley MS
Nurs Res; 1989; 38(2):81-4. PubMed ID: 2648336
[TBL] [Abstract][Full Text] [Related]
9. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province].
Hu YL;
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809
[TBL] [Abstract][Full Text] [Related]
10. Two-dimensional vs. two- plus four-dimensional ultrasound in pregnancy and the effect on maternal emotional status: a randomized study.
Rustico MA; Mastromatteo C; Grigio M; Maggioni C; Gregori D; Nicolini U
Ultrasound Obstet Gynecol; 2005 May; 25(5):468-72. PubMed ID: 15849804
[TBL] [Abstract][Full Text] [Related]
11. Does offering and performing prenatal screening influence women's attachment to their unborn child? A longitudinal randomized controlled trial.
Kleinveld JH; Timmermans DR; van den Berg M; van Eijk JT; Ten Kate LP
Prenat Diagn; 2007 Aug; 27(8):757-64. PubMed ID: 17546705
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of the decision-making process regarding amniocentesis following a screen-positive maternal serum screen result.
Kobelka C; Mattman A; Langlois S
Prenat Diagn; 2009 May; 29(5):514-9. PubMed ID: 19242922
[TBL] [Abstract][Full Text] [Related]
13. How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study.
Favre R; Duchange N; Vayssière C; Kohler M; Bouffard N; Hunsinger MC; Kohler A; Mager C; Neumann M; Vayssière C; Viville B; Hervé C; Moutel G
Prenat Diagn; 2007 Mar; 27(3):197-205. PubMed ID: 17238219
[TBL] [Abstract][Full Text] [Related]
14. The impact of two-dimensional versus three-dimensional ultrasound exposure on maternal-fetal attachment and maternal health behavior in pregnancy.
Sedgmen B; McMahon C; Cairns D; Benzie RJ; Woodfield RL
Ultrasound Obstet Gynecol; 2006 Mar; 27(3):245-51. PubMed ID: 16482614
[TBL] [Abstract][Full Text] [Related]
15. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
[TBL] [Abstract][Full Text] [Related]
16. Amniocentesis in the early second trimester of pregnancy and maternal anxiety.
Astbury J; Walters WA
Aust Fam Physician; 1979 Jun; 8(6):595-7, 599. PubMed ID: 464913
[TBL] [Abstract][Full Text] [Related]
17. Outcome of second trimester amniocentesis in twin pregnancies at Songklanagarind Hospital.
Hanprasertpong T; Kor-anantakul O; Prasartwanakit V; Leetanaporn R; Suntharasaj T; Suwanrath C
J Med Assoc Thai; 2008 Nov; 91(11):1639-43. PubMed ID: 19127782
[TBL] [Abstract][Full Text] [Related]
18. Second trimester amniotic fluid annexin A5 levels and subsequent development of intrauterine growth restriction.
Dundar O; Yoruk P; Tutuncu L; Muhcu M; Ipcioglu O; Ergur AR; Mungen E
Prenat Diagn; 2008 Oct; 28(10):887-91. PubMed ID: 18792921
[TBL] [Abstract][Full Text] [Related]
19. Anxiety and prenatal testing: do women with soft ultrasound findings have increased anxiety compared to women with other indications for testing?
Hoskovec J; Mastrobattista JM; Johnston D; Kerrigan A; Robbins-Furman P; Wicklund CA
Prenat Diagn; 2008 Feb; 28(2):135-40. PubMed ID: 18236427
[TBL] [Abstract][Full Text] [Related]
20. Amniocentesis in the third trimester of pregnancy.
O'Donoghue K; Giorgi L; Pontello V; Pasquini L; Kumar S
Prenat Diagn; 2007 Nov; 27(11):1000-4. PubMed ID: 17636852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
